Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors

Journal of Neuro-Oncology

Volumn 50, Issue 3, 2000, Pages 227-237

  Tews, D S ^a   Nissen, A ^a   Kulgen C ^a   Gaumann, A K A ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Astrocytomas; Chemotherapy; Drug resistance; Glioblastomas; Recurrence

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; METALLOTHIONEIN; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; ASTROCYTOMA; BLOOD BRAIN BARRIER; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DETOXIFICATION; DRUG SENSITIVITY; DRUG TARGETING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEMBRANE PERMEABILITY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR CLASSIFICATION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; CELL MEMBRANE; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; METALLOTHIONEIN; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034478036     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006491405010     Document Type: Article

References (55)

1. Glioblastoma
2. The biochemistry of P-glycoprotein-mediated multidrug resistance
3. The drug resistance related protein LRP is a major vault protein
4. The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump
5. Metallothionein in carcinogenesis and cancer chemotherapy
6. Overview of metallothionein
7. DNA topoisomerase-targeting antitumor agents and drug resistance
8. Transient induction of the MRP/GS-X pump and γ-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea in human glioma cells
9. Studies of induction of metallothionein in Jar (human choriocarcinoma) cells by cis and trans isomers of diaminedichloroplatinum (II) and their hydrolyzed species
10. Possible involvement of multidrug-resistance-associated protein (MDR) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells
11. Characterization and chemosensitivity of two cell lines derived from human glioblastomas
12. Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens
13. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy
14. Cell death and oxidative stress in gliomas
15. Immunohistochemical expression of P-glycoprotein and glutathione S-transferase in cerebral gliomas and response to chemotherapy
16. Mdr1 mRNA expression differs between grade III astrocytoma and glioblastomas
17. Metallothionein overexpression in human brain tumors
18. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferation potential, and survival
19. The MDR superfamily of genes and its biological implications
20. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
21. P-Glycoprotein expression in brain tumors
22. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
23. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas
24. The multidrug-resistance gene MDR1 is expressed in human glial tumors
25. Multidrug resistance gene (MDR1) expression in human brain tumors
26. MDR 1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors
27. A study of the expression four chemoresistance-related genes in human primary and metastatic brain tumours
28. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas
29. mdm2 gene mediates the expression of the mdrl gene and P-glycoprotein in a human glioblastoma cell line
30. Tissue distribution of the multidrug resistance protein
31. Lung resistance protein (LRP) expression in normal human tissues in comparison with that of MDR1 and MRP
32. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells
33. Structure and expression of the messanger RNA encoding murine multidrug resistance protein, an ATP-binding cassette transporter
34. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors
35. Vault immunofluorescence in the brain: New insights regarding the origin of microglia
36. Distribution of metallothionein in the human central nervous system
37. Expression and regulation of brain metallothionein
38. Metallothionein in the human brain
39. Localization of metallothionein in aged human brain
40. Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain
41. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanisms of its reaction with superoxide and hydroxyl radicals
42. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin-resistant rat glioblastoma cells
43. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells
44. T98G glioma cells have nicks in DNA in quiescent phase
45. Elevated DNA topoisomerase activity in nitrogen mustard-resistant human cells
46. In vivo etoposide-resistant C6 glioma cell line: Significance of altered DNA topoisomerase activity in multi-drug resistance
47. Etoposide sensitivity of radioresistant human glioma cell lines
48. Proliferation dependence of topoisomerase II mediated drug action
49. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells
50. Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts
51. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain-barrier and to increased sensitivity to drugs
52. P-glycoprotein-mediated efflux transport of anti-cancer drugs at the blood-brain barrier
53. Advances in brain tumor chemosensitivity
54. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein
55. Mutations of the p53 gene in human astrocytic tumours correlates with increase resistance to DNA-damaging agents but not to antimicrotubule anti-cancer agents